Form 4: Sarepta Therapeutics Executive Bilal Arif Reports Stock Disposals to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Bilal Arif, Chief Tech Ops Officer of Sarepta Therapeutics, reports disposing of shares to cover tax withholding obligations related to vesting of restricted stock units.

Summary

  • Bilal Arif, Chief Tech Ops Officer at Sarepta Therapeutics, filed a Form 4 with the SEC.
  • The form details the disposal of common stock to satisfy tax withholding obligations.
  • On March 7, 2024, 506 shares were disposed of at a price of $120.49.
  • On March 8, 2024, 472 shares were disposed of at a price of $123.14.
  • Following these transactions, Arif directly owns 25,222 shares of Sarepta Therapeutics common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing simply reports stock disposals for tax purposes, a routine event.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be influenced by factors such as vesting schedules, tax planning, and personal financial decisions. It's important to consider the context of these transactions when evaluating their potential impact.

Stakeholder Impact

  • The stock disposal may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates

DateDescription
03/07/2022Date of restricted stock units grant related to the March 8, 2024 disposal.
03/06/2023Date of restricted stock units grant related to the March 7, 2024 disposal.
03/07/2024Date of disposal of 506 shares at $120.49.
03/08/2024Date of disposal of 472 shares at $123.14.
03/11/2024Date of signature of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.